This not only provides a potential tool for other researchers to continue to explore the deeper mechanism of HIF‐1α in endometriosis, but also offers a choice for the therapeutic strategy of endometriosis targeting HIF‐1α, which is different from small molecule inhibitors. This evidence concerns the gene HIF1A and endometriosis.